SUBSCRIBE: eNewsletter
- TRENDING:
- AMD
- DME
- Ophthalmic Tech's Community
- Money Matters
Diabetic Retinopathy
August 06, 2017By Cheryl Guttman Krader
In complicated retinal detachment cases where the retina fails to reattach after completing the usual steps, retinectomy is a better technique than relaxing retinotomy–and the retinectomy is best done incrementally under air, said Steve Charles, MD. 
May 22, 2017By Cheryl Guttman Krader
Anti-VEGF therapy for Zone I retinopathy of prematurity (ROP) is associated with better structural and functional outcomes than laser therapy, but also a longer recurrence risk period, said Helen A. Mintz-Hittner, MD. Aflibercept rivals laser for diabetic retinopathy
May 14, 2017
Intravitreal aflibercept worked better than panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR) in a new head-to-head trial, according to researchers. 
April 09, 2017By Lynda Charters
New imaging technologies, such as ultra-wide-field fluorescein angiography and optical coherence tomography angiography, are providing more details about retinal diseases than previous imaging technologies, leading to better understanding of disease processes. 
February 15, 2017By Vanessa Caceres
The use of 27-gauge instrumentation provides several surgical advantages compared with larger tools in retinal surgery, particularly in difficult cases. 
February 01, 2017By Cheryl Guttman Krader
Ophthalmology may be one step closer to the hope of providing artificial vision for individuals affected by virtually all forms of blindness. Computer-based image analysis promising for ROP
January 23, 2017By Laird Harrison
Computers may make more reliable diagnoses of plus disease in retinopathy of prematurity than individual clinicians, a researcher reports. 
January 23, 2017By Lynda Charters
Pregnant patients require special care and surveillance when retinal diseases are present. 
November 28, 2016By Cheryl Guttman Krader
Retina specialists who are Diabetic Retinopathy Clinical Research Network investigators offer views on whether laser panretinal photocoagulation or anti-VEGF therapy deserves consideration as first-line treatment for proliferative diabetic retinopathy.